How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement (pages 765–774)J. Bousquet, H. J. Schünemann, P. J. Bousquet, C. Bachert, G. W. Canonica, T. B. Casale, P. Demoly, S. Durham, K.-H. Carlsen, H.-J. Malling, G. Passalacqua, F. E. R. Simons, J. Anto, C. E. Baena-Cagnani, K.-C. Bergmann, T. Bieber, A. H. Briggs, J. Brozek, M. A. Calderon, R. Dahl, P. Devillier, R. Gerth van Wijk, P. Howarth, D. Larenas, N. G. Papadopoulos, P. Schmid-Grendelmeier and T. Zuberbier
Article first published online: 18 APR 2011 | DOI: 10.1111/j.1398-9995.2011.02590.x